Regulatory & Legal

South Korean firm Neurophet wins its third FDA clearance for an AI tool that precisely tracks Alzheimer's therapy side effects, eyeing U.S. expansion.

China's 2026 tax overhaul offers major breaks for the domestic service industry. E-Home is seizing the opportunity to invest in AI and service quality.

India's top university is planting its flag in the US, launching a new foundation to accelerate deep-tech startups and forge a transatlantic tech pipeline.

Australian biotech Immutep reaches a key milestone in its Phase III trial for a novel lung cancer therapy, a major step in a multi-billion dollar market.

With a new celebrity ad, CoreWeave is making a play for AI dominance. But can its specialized tech overcome financial risks and challenge industry giants?

For the 14th straight year, Herzing University earns top U.S. News rankings. Discover the model of support and career focus driving its sustained success.

Marex's acquisition of Webb Traders signals a major push into automated equity derivatives, aiming to internalize hedging and challenge market norms.

The fintech firm is pivoting hard into digital assets, planning to mine Bitcoin Cash while launching a novel crypto life insurance business in Bermuda.

Indonesian forestry giant APP Group holds its 'B' score in a key environmental audit. What does this mean for sustainability in a high-stakes industry?

After a bitter legal battle across Europe, Maxeon and Aiko sign a landmark patent agreement, reshaping the global market for high-efficiency solar tech.

A new 7,500-participant study will test a cfDNA-based screen to identify high-risk pregnancies months before symptoms appear, a potential paradigm shift.

As HUTCHMED prepares to unveil its 2025 financials, investors weigh a complex picture of global drug success, domestic pressures, and pipeline promise.

Akeso's innovative dual-action antibody secures its fifth breakthrough nod, offering a lifeline for patients with advanced biliary tract cancer.

Former Senator Joe Manchin and pharma exec Heather Manchin join BlinkRx, bringing political and industry muscle to the fight for affordable medicine.

A 141-km road connecting three remote First Nations in Manitoba is approved, balancing economic hopes with strict environmental oversight.

Canadian biotech Satellos Bioscience seeks a Nasdaq listing and a $50M public offering to advance its promising muscle regeneration drug for Duchenne.

As Amwell prepares its 2025 results, investors watch to see if its strategic pivot to profitability can redefine the future of digital healthcare.

AI-powered reAlpha has launched a new platform to unify the fragmented homebuying journey. Can its integrated approach truly simplify the process for buyers?

With a new focus on eye disease and fresh funding, Surrozen will present its novel Wnt-based pipeline to investors. What's at stake for the future of sight?

After a blockbuster IPO raised nearly $300 million, dermatologist-founded Veradermics is poised to challenge the hair loss market with its new oral pill.